These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10929853)

  • 1. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy.
    Armstrong K; Popik S; Guerra C; Ubel PA
    Med Decis Making; 2000; 20(3):308-13. PubMed ID: 10929853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women?
    Scheid DC; Coleman MT; Hamm RM
    J Am Board Fam Pract; 2003; 16(4):270-7. PubMed ID: 12949027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.
    Armstrong K; Chen TM; Albert D; Randall TC; Schwartz JS
    Obstet Gynecol; 2001 Dec; 98(6):996-1003. PubMed ID: 11755544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
    MacDougall LA; Barzilay JI; Helmick CG
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause.
    Lobo RA; Pickar JH; Stevenson JC; Mack WJ; Hodis HN
    Atherosclerosis; 2016 Nov; 254():282-290. PubMed ID: 27745704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and breast cancer: revisiting the issues.
    DeGregorio MW; Taras TL
    J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of risk on preference values: implications for evaluations of postmenopausal osteoporosis therapy.
    Coyle D; Wells G; Graham I; Lee KM; Peterson JE; Papadimitropoulos E
    Value Health; 2001; 4(5):385-91. PubMed ID: 11705129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences of hormone replacement therapy on postmenopausal women's health perceptions.
    Blümel JE; Castelo-Branco C; Kerrigan N; Cancelo MJ; Blümel B; Haya J; Flores M; Carvajal MC; Sarrá S
    Menopause; 2003; 10(3):235-40. PubMed ID: 12792296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer.
    Chlebowski RT; McTiernan A
    J Clin Oncol; 1999 Jan; 17(1):130-42. PubMed ID: 10458226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing view of hormone replacement therapy.
    Vogel RA
    Rev Cardiovasc Med; 2003; 4(2):68-71. PubMed ID: 12776015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy.
    Couzi RJ; Helzlsouer KJ; Fetting JH
    J Clin Oncol; 1995 Nov; 13(11):2737-44. PubMed ID: 7595732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function.
    Huang KE; Xu L; I NN; Jaisamrarn U
    Maturitas; 2010 Mar; 65(3):276-83. PubMed ID: 20018469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of hormone replacement therapy in postmenopausal women with renal failure.
    Stehman-Breen CO; Gillen D; Gipson D
    Kidney Int; 1999 Dec; 56(6):2243-7. PubMed ID: 10594801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
    Bakken K; Eggen AE; Lund E
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coping with menopausal symptoms: An internet survey of Belgian postmenopausal women.
    Depypere H; Pintiaux A; Desreux J; Hendrickx M; Neven P; Marchowicz E; Albert V; Leclercq V; Van den Branden S; Rozenberg S
    Maturitas; 2016 Aug; 90():24-30. PubMed ID: 27282790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis beliefs and antiresorptive medication use.
    Cline RR; Farley JF; Hansen RA; Schommer JC
    Maturitas; 2005 Mar; 50(3):196-208. PubMed ID: 15734601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of intentions to use hormone replacement therapy in clinical postmenopausal women.
    Simpson EE
    Climacteric; 2012 Apr; 15(2):173-80. PubMed ID: 22132771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
    Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
    Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.